Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China · Delayed Price · Currency is CNY 4.310
+0.030 (0.70%)
Jan 23, 2026, 3:00 PM CST
SHA:603363 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 1,812 | 579.35 | -3,651 | -1,038 | -1,520 | 572.99 | Upgrade |
Depreciation & Amortization | 832.04 | 832.04 | 1,235 | 1,290 | 1,042 | 327.21 | Upgrade |
Other Amortization | 96.73 | 96.73 | 86.97 | 59.47 | 49.33 | 38.66 | Upgrade |
Loss (Gain) From Sale of Assets | -46.16 | -46.16 | 38.28 | -2.56 | 2.38 | 3.82 | Upgrade |
Asset Writedown & Restructuring Costs | 174.46 | 174.46 | 470.43 | 51.24 | 42.49 | 39.63 | Upgrade |
Loss (Gain) From Sale of Investments | -1,526 | -1,526 | 5.83 | 14.44 | 37.42 | -5.89 | Upgrade |
Provision & Write-off of Bad Debts | 55.64 | 55.64 | 46.16 | 24.82 | 56.75 | 62.39 | Upgrade |
Other Operating Activities | -1,464 | 215.64 | 874.16 | 791.48 | 555.47 | 624.58 | Upgrade |
Change in Accounts Receivable | -3,695 | -3,695 | -301.33 | -47.36 | -146.7 | -325.2 | Upgrade |
Change in Inventory | 455.31 | 455.31 | 2,073 | -1,223 | -1,290 | -1,449 | Upgrade |
Change in Accounts Payable | 2,734 | 2,734 | -15.19 | 796.91 | 1,640 | 501.38 | Upgrade |
Change in Other Net Operating Assets | 0.73 | 0.73 | 55.74 | 51.82 | 54.48 | 62.07 | Upgrade |
Operating Cash Flow | -563.61 | -116.78 | 984.01 | 663.64 | 524.29 | 406.02 | Upgrade |
Operating Cash Flow Growth | - | - | 48.27% | 26.58% | 29.13% | 3.01% | Upgrade |
Capital Expenditures | -212.64 | -262.68 | -511.77 | -1,499 | -2,709 | -3,293 | Upgrade |
Sale of Property, Plant & Equipment | 15.85 | 164.82 | 78.18 | 13.83 | 12.06 | 35.05 | Upgrade |
Cash Acquisitions | -2.49 | -2.1 | -56.54 | -64.89 | -63.45 | -466.57 | Upgrade |
Divestitures | 55.81 | 29.8 | 246.99 | -0.19 | 5.6 | - | Upgrade |
Investment in Securities | -3.82 | 28.15 | 3.77 | -98.41 | -19.76 | -164.69 | Upgrade |
Other Investing Activities | -3.5 | 2.94 | -82.71 | -54.61 | -32.2 | -113.46 | Upgrade |
Investing Cash Flow | -150.8 | -39.07 | -322.08 | -1,703 | -2,806 | -4,002 | Upgrade |
Long-Term Debt Issued | - | 960.92 | 7,534 | 6,568 | 5,995 | 5,054 | Upgrade |
Long-Term Debt Repaid | - | -1,403 | -8,066 | -6,440 | -4,427 | -2,353 | Upgrade |
Net Debt Issued (Repaid) | -367.52 | -442.46 | -532.77 | 127.84 | 1,568 | 2,701 | Upgrade |
Issuance of Common Stock | 1,709 | 1,709 | - | 1,618 | 1,064 | 1,457 | Upgrade |
Repurchase of Common Stock | -35.64 | -35.64 | -8.44 | -61.82 | -3.11 | -12.36 | Upgrade |
Common Dividends Paid | -53.48 | -76.39 | -294.86 | -373.67 | -345.77 | -186.09 | Upgrade |
Other Financing Activities | -520.28 | -18.52 | -294.26 | -89.69 | -83.36 | -34.94 | Upgrade |
Financing Cash Flow | 731.58 | 1,135 | -1,130 | 1,220 | 2,200 | 3,925 | Upgrade |
Foreign Exchange Rate Adjustments | 0.02 | 0 | -2.06 | -2.05 | -0.11 | -0.23 | Upgrade |
Net Cash Flow | 17.2 | 979.64 | -470.46 | 178.55 | -82.54 | 328.48 | Upgrade |
Free Cash Flow | -776.26 | -379.46 | 472.23 | -835.31 | -2,184 | -2,887 | Upgrade |
Free Cash Flow Margin | -9.50% | -4.33% | 2.43% | -3.86% | -12.11% | -25.06% | Upgrade |
Free Cash Flow Per Share | -0.36 | -0.44 | 0.55 | -1.08 | -3.36 | -4.58 | Upgrade |
Cash Interest Paid | 19.48 | 19.48 | 67.44 | 21.16 | 29.12 | 41.83 | Upgrade |
Cash Income Tax Paid | 82.26 | 69.39 | 108.27 | 99.93 | 85.41 | 40.26 | Upgrade |
Levered Free Cash Flow | -3,483 | -2,317 | 527.61 | -1,115 | -1,244 | -2,629 | Upgrade |
Unlevered Free Cash Flow | -3,223 | -1,910 | 871.35 | -799.01 | -982.65 | -2,518 | Upgrade |
Change in Working Capital | -498.22 | -498.22 | 1,878 | -526.51 | 257.88 | -1,257 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.